Zai Lab (ZLAB) Net Cash Flow (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Net Cash Flow of -$28.6 million for Q1 2026, down 109.31% year-on-year from $307.6 million in Q1 2025, and up 24.16% on a QoQ basis from -$37.7 million in Q4 2025.
Zai Lab (ZLAB) Net Cash Flow (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Net Cash Flow for 9 consecutive years, with -$28.6 million the latest figure, recorded in Q1 2026.
- Quarterly Net Cash Flow fell 109.31% year-over-year to -$28.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$106.8 million (down 200.1% YoY) and the FY2025 annual result came in at $229.4 million, up 195.53% from the prior year.
- Net Cash Flow improved to -$28.6 million in Q1 2026 per ZLAB's latest filing, from -$37.7 million in the prior quarter.
- Over the last five years, Net Cash Flow for ZLAB reached as high as $442.6 million in Q3 2022 and fell as low as -$165.7 million in Q4 2024.
- A 5-year average of -$12.0 million and a median of -$28.6 million in 2026 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow tumbled 247229.85% — and 2025, when it surged 883.31%.
- Year by year, Net Cash Flow stood at -$113.9 million in 2022, then surged by 99.94% to -$67000.0 in 2023, then slumped by 247229.85% to -$165.7 million in 2024, then jumped by 77.22% to -$37.7 million in 2025, then increased by 24.16% to -$28.6 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$28.6 million, -$37.7 million, and -$15.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -28.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.63 Mn |
| Mar 31, 2026 | -28.63 Mn |
| Dec 31, 2025 | -37.75 Mn |
| Dec 31, 2025 | -37.75 Mn |
| Sep 30, 2025 | -15.30 Mn |
| Sep 30, 2025 | -15.30 Mn |
| Jun 30, 2025 | -25.10 Mn |
| Jun 30, 2025 | -25.10 Mn |
| Mar 31, 2025 | 307.58 Mn |
| Mar 31, 2025 | 307.58 Mn |
| Dec 31, 2024 | -165.71 Mn |
| Dec 31, 2024 | -165.71 Mn |
| Sep 30, 2024 | -14.50 Mn |
| Sep 30, 2024 | -14.50 Mn |
| Jun 30, 2024 | -20.70 Mn |
| Jun 30, 2024 | -20.70 Mn |
| Mar 31, 2024 | -39.27 Mn |
| Mar 31, 2024 | -39.27 Mn |
| Dec 31, 2023 | -67,000.00 |
| Dec 31, 2023 | -67,000.00 |